диссертации / 122

131

Vol. 7. - № 7. - P. 391 - 398.

232.Vasiliauskiene, L. Prevalence and clinical significance of anti-keratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis/ L. Vasiliauskiene, A. Wiik, M. Hoier-Madsen// Ann. Rheum. Dis. – 2001. - Vol. 60. - P. 459 - 466.

233.Vencovsky, J. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis/ J. Vencovsky, S. Machacek, L. Sedova et al.// Ann. Rheum. Dis. - 2003. - Vol. 62. - P. 427 - 430.

234.Verheijden, G. F. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis./ G. F. Verheijden, A. W. Rijnders, E. Bos et al.// Arthritis Rheum. - 1997. - Vol. 40. - P. 1115 - 1125.

235.Vincent, C. Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis/ C. Vincent, M. Simon, M. Sebbag et al.// J. Rheumatol. - 1998. – Vol. 25. - № 5. - P. 838 - 846.

236.von Landenberg, P. A new antigenic epitope localized within human kappa light chains specific for rheumatoid arthritis and systemic lupus erythematosus/ P. von Landenberg, C. von Landenberg, M. Grundl et al. // J. Autoimmun. - 1999. - Vol. 13. - № 1. - P. 83 - 87.

237.Vossenaar, E. R. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin/ E. R.Vossenaar, N. Despres, E. Lapointe et al. //Arthritis Res. Ther. - 2004. - Vol. 6. - P. 142 – 150.

238.Vossenaar, E. Citrullination of synovial proteins in murine models of rheumatoid arthritis/ E. Vossenaar, S. Nijenhuis, M. Helsen, et al. // Arthritis Rheum. - 2003. - Vol. 48. - № 9. - P. 2489 - 2500.

239.Vossenaar, E. R. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages/ E. R. Vossenaar, T. R. Radstake, A. van der Heijden et al. // Ann. Rheum. Dis. - 2004. - Vol. 63. - P. 373 - 381.

132

240.Vossenaar, E. R. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue/ E. R. Vossenaar, T. J. Smeets, M. C. Kraan, et al.// Arthritis Rheum. - 2004. - Vol. 50. - № 11. - P. 3485 - 3494.

241.Vossenaar, E. R. Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis/ E .R. Vossenaar, van W. J. Venrooij // Arthritis Res. Ther. – 2004. - vol. 6. - P. 107 – 111.

242.Waaler, E. On the occurance of factoring human serum activating the specific agglutination of sheep blood carpuscule/ E. Waaler // Acta. Pathol. Microbiol. Immunol. Scand. - 1939. - Vol. 17. - P. 172 - 182.

243.Wagner, E. Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis/ E. Wagner, M. Skoumal, P. M. Bayer, K. Klaushofer // Rheumatol. - 2009. -Vol. 29 - P. 1315 - 1321.

244.Walther, J. An important step towards completing the rheumatoid arthritis cycle/ J. Walther, W. J. van Venrooij and Ger JM Pruijn// Arthritis Research & Therapy. - 2008. - Vol. 10. - P. 117.

245.Wener, M. Multiplex, megaplex, index, and complex: the present and future of laboratory diagnostics in rheumatology/ M. Wener // Arthritis Research & Therapy. - 2011. -Vol. 13. - P. 134.

246.Wong, C. E. Lateral Flow Immunoassay/ C. E. Wong, H. Y. Tse// Springer. - 2009. - P. 3 - 5.

247.Xie, Q. B. Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis/ Q. B. Xie, G. Yin// Sichuan Da Xue Xue Bao Yi Xue Ban. -2009. - Vol. 40, - № 3. - P. 508 - 512.

248.Xue, C. Characterisation of fibroblast-like cells in pannus lesions of patients with rheumatoid arthritis sharing properties of fibroblasts and chondrocytes/ C. Xue, M. Takahashi, T. Hasunuma et al.// Ann. Rheum. Dis. - 1997. - Vol. 56. - P.

262- 267.

249.Youinou, P. Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases/ P.

133

Youinou, P. L. Goff, C. B. Colaco et al.// Ann. Rheum. Dis. - 1985. - Vol. 44. - P. 450 - 454.

250.Young, B. J. Anti-keratin antibodies in rheumatoid arthritis/ B. J. Young, R. K. Mallya, R. D. Leslie et al.// Br. Med. J. - 1979. - Vol. 2. - P. 97 - 99.

251.Zablocki, R. W. A Novel Diagnostic Marker for RA, Anti-MCV/ R. W. Zablocki, A. Van der Helm-van Mil, T. Huizinga , S. Rao// Arthritis Rheum. - 2010. - Vol. 62. - Suppl 10. - P. 660.

252.Zendman, A. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis/ A. Zendman, W. van Venrooij, G. Pruijn// Rheumatology. - 2006. - Vol.

45.- P. 20 – 25.

253.Zeng, X. Diagnostic value of anticyclic citrullinated peptide antibody in patients with rheumatoid arthritis/ X. Zeng, M. Ai, X. Tian et al.// J. Rheumatol. - 2003. - Vol. 30. - P. 1451 - 1455.

254.Zhao, J. Is it necessary to combine detection of anticitrullinated protein antibodies in the diagnosis of rheumatoid arthritis?/ J. Zhao, X. Liu, Z. Wang et al.// J. Rheumatol. – 2010. - Vol. 37. - № 12. - P. 2462 - 2465.

255.Zhou, X. Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research/ X. Zhou, M. S. Fragala, J. McElhaney et al.// Curr. Opin. Clin. Nutr. Metab. Care. - 2010. - Vol. 13. - № 5. – P. 541 - 547.

256.Zimmermann, C. Diagnostic value of anti-ccp and anti-mutated citrullinated vimentin (MCV) testing in patients with rheumatoid arthritis/ C. Zimmermann, E. Hoefler, G. Steiner // Ann. Rheum. Dis. - 2008. - Vol. 67. - Suppl. II. - P. 149.

257.Zweig, M. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine/ M. Zweig, G. Campbell// Clinical Chemistry. - 1993. - Vol. 39. - № 8. - P. 561 – 577.